Cargando…

Preventive Pap-smears: balancing costs, risks and benefits.

The pattern of spontaneous screening for cervical cancer by general practitioners and gynaecologists in The Netherlands is compared with an efficient screening policy resulting from a cost-effective study. Spontaneous screening tends to start and stop too early in a woman's life, and leaves too...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ballegooijen, M., Habbema, J. D., van Oortmarssen, G. J., Koopmanschap, M. A., Lubbe, J. T., van Agt, H. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977773/
https://www.ncbi.nlm.nih.gov/pubmed/1616867
_version_ 1782135334041026560
author van Ballegooijen, M.
Habbema, J. D.
van Oortmarssen, G. J.
Koopmanschap, M. A.
Lubbe, J. T.
van Agt, H. M.
author_facet van Ballegooijen, M.
Habbema, J. D.
van Oortmarssen, G. J.
Koopmanschap, M. A.
Lubbe, J. T.
van Agt, H. M.
author_sort van Ballegooijen, M.
collection PubMed
description The pattern of spontaneous screening for cervical cancer by general practitioners and gynaecologists in The Netherlands is compared with an efficient screening policy resulting from a cost-effective study. Spontaneous screening tends to start and stop too early in a woman's life, and leaves too many women overscreened or unprotected. The combination in young age of a low incidence of invasive cancer and a high incidence of regressive lesions explains relative ineffectiveness and harmfulness of present screening practice. When screening would take place between ages 30 and at least 60, with intervals of about 5 years, as many lives could be saved for half the costs and with only 60% of the unnecessary referrals and treatments. Much attention should be paid to the coverage of the target population. Therapeutic follow-up policies for dysplastic lesions should be restrained.
format Text
id pubmed-1977773
institution National Center for Biotechnology Information
language English
publishDate 1992
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19777732009-09-10 Preventive Pap-smears: balancing costs, risks and benefits. van Ballegooijen, M. Habbema, J. D. van Oortmarssen, G. J. Koopmanschap, M. A. Lubbe, J. T. van Agt, H. M. Br J Cancer Research Article The pattern of spontaneous screening for cervical cancer by general practitioners and gynaecologists in The Netherlands is compared with an efficient screening policy resulting from a cost-effective study. Spontaneous screening tends to start and stop too early in a woman's life, and leaves too many women overscreened or unprotected. The combination in young age of a low incidence of invasive cancer and a high incidence of regressive lesions explains relative ineffectiveness and harmfulness of present screening practice. When screening would take place between ages 30 and at least 60, with intervals of about 5 years, as many lives could be saved for half the costs and with only 60% of the unnecessary referrals and treatments. Much attention should be paid to the coverage of the target population. Therapeutic follow-up policies for dysplastic lesions should be restrained. Nature Publishing Group 1992-06 /pmc/articles/PMC1977773/ /pubmed/1616867 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
van Ballegooijen, M.
Habbema, J. D.
van Oortmarssen, G. J.
Koopmanschap, M. A.
Lubbe, J. T.
van Agt, H. M.
Preventive Pap-smears: balancing costs, risks and benefits.
title Preventive Pap-smears: balancing costs, risks and benefits.
title_full Preventive Pap-smears: balancing costs, risks and benefits.
title_fullStr Preventive Pap-smears: balancing costs, risks and benefits.
title_full_unstemmed Preventive Pap-smears: balancing costs, risks and benefits.
title_short Preventive Pap-smears: balancing costs, risks and benefits.
title_sort preventive pap-smears: balancing costs, risks and benefits.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977773/
https://www.ncbi.nlm.nih.gov/pubmed/1616867
work_keys_str_mv AT vanballegooijenm preventivepapsmearsbalancingcostsrisksandbenefits
AT habbemajd preventivepapsmearsbalancingcostsrisksandbenefits
AT vanoortmarssengj preventivepapsmearsbalancingcostsrisksandbenefits
AT koopmanschapma preventivepapsmearsbalancingcostsrisksandbenefits
AT lubbejt preventivepapsmearsbalancingcostsrisksandbenefits
AT vanagthm preventivepapsmearsbalancingcostsrisksandbenefits